Caricamento...
Anti-angiogenic therapy for ovarian cancer
Angiogenesis is a known hallmark in cancer and plays a crucial role in ovarian cancer carcinogenesis and invasion. Anti- angiogenic agents are active in ovarian cancer treatment either as monotherapy or combined with chemotherapy, immunotherapy or poly ADP ribose polymerase (PARP) inhibitors. We rev...
Salvato in:
| Pubblicato in: | EJC Suppl |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7573465/ https://ncbi.nlm.nih.gov/pubmed/33240446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejcsup.2020.02.003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|